Alzheimer Science’s Post

The neurostimulation procedure Transcranial Pulse Stimulation (TPS) for the treatment of Alzheimer's disease is being intensively studied in clinical trials worldwide. The data is expansive and shows the potential that low-energy shock waves have in the therapy of neurodegenerative diseases such as Alzheimer's – and they can be administered on an outpatient and non-invasive basis.   In Germany, Prof. Ulrich Sprick and his team at the Alexius/Josef Hospital in Neuss/ North Rhine-Westphalia, are playing a leading role in the scientific work on Transcranial Pulse Stimulation (TPS) and in TPS therapy. In the newly founded “Center for Neurostimulation”, the scientists are investigating the innovative therapy method, which is based on targeted stimulation of the central nervous system.   Prof. Sprick and his team are offering a free information event for those affected and their relatives on the possibilities of neurostimulation in people with Alzheimer's dementia. This will take place on Monday, November 18, 2024, starting at 5 p.m. – see an article in the newspaper Rhein-Ruhr:   https://lnkd.in/d8pcGHMw   #transcranialpulsestimulation #tps #neurostimulation #tpsscience #tpsstudies #alzheimers #alzheimerstherapy #profulrichsprick #centerforneurostimulation #alexiusjosefclinic #alzheimersshockwaves #shockwavetherapy  

Further possible mechanisms of action of shock wave therapy: Prof. Lars Wojtecki, Medical Director of the Kempen Teaching Hospital of the University of Düsseldorf, was recently able to demonstrate in a study that Transcranial Pulse Stimulation (TPS) in Alzheimer's disease shows possibly that the shock waves also influence the so-called glymphatic system of the brain, which is responsible for cleansing the brain of waste products, and it was shown that electrical modulations take place through the use of TPS. These findings could reveal further modules of the interaction of the various mechanisms of action that can halt or delay the progression of the disease in many sufferers and significantly improve the quality of life.   The number of patients affected by Alzheimer's disease is increasing dramatically worldwide, so new therapies are urgently needed. The possibilities of TPS as an additive treatment option for Alzheimer's disease are therefore being intensively researched internationally, and interest among experts is growing in line with the expansion of the study situation. This was also evident this weekend at the 1st International TPS Symposium at the Alexius/Josef Hospital in Neuss, where a big number of experts from around the world discussed current research on TPS.   However, the fact that it is also important for those affected, their relatives and society to learn about the latest research findings and thus about new treatment options, especially for methods such as TPS that are already available in clinics and practices, is also linked to an appeal to the media: It is also up to them to report and provide information about innovative ways of treating one of the greatest pandemics of our time.   In addition to other media in TV and print, the BILD newspaper (one of the biggest newspapers in Germany) once again did this yesterday, reporting carefully on Prof. Wojtecki's work on TPS:   https://lnkd.in/dVtxzDp3   #alzheimers #alzheimerstherapy #transcranialpulsestimulation #tps #larswojtecki #tpsstudies #tpsthemediea #bildnewspaper #bildtps #newresearchontps

🧠🚨 A Threat to Neurological Care | Silke Biethahn, Martina Goeldlin, Urs Fischer, on behalf of the SNS Board 🚨🧠 Switzerland is facing a growing shortage of neurologists, while the demand for their services is increasing. This is driven by various neurological conditions that affect a significant proportion of the population. Long waiting times for appointments are also causing many patients to turn to emergency care, putting additional strain on healthcare facilities. The possible introduction of admission restrictions could further exacerbate the shortage of neurologists and have a negative impact on patient care. The SNS strongly opposes such measures and calls for alternative solutions to ensure that all patients have access to high-quality neurological care. Link to the article: https://lnkd.in/eGp7n3Mz #NeurologySwitzerland #SNS #STRONGNEUROLOGY

Further possible mechanisms of action of shock wave therapy: Prof. Lars Wojtecki, Medical Director of the Kempen Teaching Hospital of the University of Düsseldorf, was recently able to demonstrate in a study that Transcranial Pulse Stimulation (TPS) in Alzheimer's disease shows possibly that the shock waves also influence the so-called glymphatic system of the brain, which is responsible for cleansing the brain of waste products, and it was shown that electrical modulations take place through the use of TPS. These findings could reveal further modules of the interaction of the various mechanisms of action that can halt or delay the progression of the disease in many sufferers and significantly improve the quality of life.   The number of patients affected by Alzheimer's disease is increasing dramatically worldwide, so new therapies are urgently needed. The possibilities of TPS as an additive treatment option for Alzheimer's disease are therefore being intensively researched internationally, and interest among experts is growing in line with the expansion of the study situation. This was also evident this weekend at the 1st International TPS Symposium at the Alexius/Josef Hospital in Neuss, where a big number of experts from around the world discussed current research on TPS.   However, the fact that it is also important for those affected, their relatives and society to learn about the latest research findings and thus about new treatment options, especially for methods such as TPS that are already available in clinics and practices, is also linked to an appeal to the media: It is also up to them to report and provide information about innovative ways of treating one of the greatest pandemics of our time.   In addition to other media in TV and print, the BILD newspaper (one of the biggest newspapers in Germany) once again did this yesterday, reporting carefully on Prof. Wojtecki's work on TPS:   https://lnkd.in/d6S6BVFZ   #alzheimers #alzheimerstherapy #transcranialpulsestimulation #tps #larswojtecki #tpsstudies #tpsthemediea #bildnewspaper #bildtps #newresearchontps

Around 69 million people sustain a traumatic brain injury (TBI) around the world every year. This is an alarming figure, given diagnoses are often missed or delayed for those suffering from them, highlighting the need for improved diagnostic tools. The ability to swiftly and accurately diagnose TBI is crucial for effective treatment and improved patient outcomes. I’m proud to announce a new partnership between @Roche and the @Biomedical Advanced Research and Development Authority (BARDA), a collaborative effort that seeks to leverage Roche's expertise in diagnostics and neurology and BARDA's commitment to advancing medical preparedness. Together, we’re striving to improve the diagnosis accuracy and assessment of TBI severity in order to expedite patient triage in various healthcare settings, including emergency departments and trauma centers. Read more about the partnership here: https://lnkd.in/dWXiy6Es  #neurology #diagnostics #partnership 

I am cited on the Institut du Cerveau – Paris Brain Institute 2024 flyer. Je suis cité sur le prospectus 2024 de l'Institut du Cerveau – Paris Brain Institute Hypoxic-Ischemic Encephalopathy Newborn Neurodigital Project A new decision support tool has been created for the management of full-term newborns, in the context of perinatal asphyxia. Of the 5 million children born each year in Europe, 20,000 experience oxygen deprivation at birth. 5,000 of them will die, the rest will suffer from physical or cognitive disabilities to varying degrees. Placing the child in hypothermia (33°-34°) for 72 hours can considerably reduce or even eliminate the neurological consequences of HIE, thus limiting the risk of disability. This treatment has two major constraints: - Brain damage must be confirmed by an electroencephalogram. - Treatment must begin before the child's 6th hour of life. At the initiative of Anne-Isabelle Vermersch, a neurophysiologist at Armand-Trousseau hospital, researchers have developed a tool capable of synthesizing the normality or abnormality of brain activity in a single image. Anne-Isabelle Vermersch #ai4good #babyhealth

Research and development are essential drivers of innovation, fueling progress and paving the way for technological, economic, and social advancements. Ongoing research in the health sciences has enabled us to overcome deadly diseases such as polio and tuberculosis and tackle many health challenges. Brain research is the key to unlocking new possibilities for understanding, preventing, and treating neurological conditions. According to the Centre for Addiction and Mental Health (CAMH), in any given year, 1 in 5 Canadians experiences a mental illness. As Ontario’s population grows and mental health becomes an increasing focus, investing in brain research presents a powerful opportunity to enhance the well-being of Ontarians and build a sustainable healthcare system. By investing in brain science research, Ontario takes a proactive approach to shaping a healthier future. The Ontario government is celebrating the completion of the new Centre for Brain Science at Sunnybrook Health Sciences Centre. The province has invested $60 million to support the state-of-the-art facility dedicated to brain science research and care, connecting those with complex mental health conditions to the care they need. The Garry Hurvitz Brain Sciences Centre is expected to begin delivering care to patients by January 2025. It will be the first of its kind in Canada, featuring over 120,000 square feet of space and serving as a hub for mental health care and innovative research. Services for youth and adults include: - 11 new inpatient, fully private mental health beds to connect people to intensive care - A classroom for youth to continue their education while in treatment - Neurology and neuromodulation services for people with severe medication and treatment-resistant mental health disorders - Brain health clinics to support people with Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s, movement disorders, stroke, seizure disorders, headaches and other neurological conditions - Sleep laboratory services, including sleep rooms and ambulatory clinics To learn more, please follow this link: https://shorturl.at/rlLR7

RIGHT VERSUS LEFT TEMPORAL LOBE SEMIOLOGY IN DEMENTIA: Lessons from two cases with focal frontotemporal dementia syndromes Focal atrophy of the left anterior temporal lobe has been associated with the semantic type of primary progressive aphasia evolving to semantic dementia. In contrast, focal atrophy of the right temporal lobe has more recently been described as a controverse entity reported as the right temporal variant of FTD. We describe two cases of FTD dementia syndromes: in Case 1, atrophy of the right temporal lobe led to significant behavioural impairment and difficulties in recognizing known people. In Case 2, atrophy of the left temporal lobe was associated with severe aggressive, ritualistic behaviour and aphasia. Authors: Breno José Alencar Pires Barbosa, et al in Journal of NeuropsychologyVolume 18, Issue 3, First published: 09 May 2024 Source: https://lnkd.in/ggUidYWg

👐✨ EFSHT Highlights New PhD Research! ✨👐We’re excited to share a groundbreaking PhD thesis on aspects of fine motor performance in neurological disorders affecting hand function. This vital research sheds light on innovative approaches to enhance therapy and improve outcomes for patients with neurological challenges.Join us in celebrating this significant advancement in hand therapy knowledge and practice! 🩺📚Stay connected for more updates on cutting-edge research. 🌟 #EFSHT #HandTherapy #NeurologicalDisorders #PhDResearch

In a new article for Medical Economics, Alvaro Pascual-Leone, MD, PhD — Chief Medical Officer and Co-Founder at Linus Health, Professor of Neurology at Harvard Medical School, and Medical Director at the Deanna and Sidney Wolk Center for Memory Health at Hebrew SeniorLife — dives into what primary care physicians can do to prevent and screen for dementia. Read the article now to learn how a new approach to dementia, including better screening tools and brain health action plans, can greatly benefit your patients. #dementia #Alzheimersdisease #Alzheimers #brainhealth #primarycare